Triazolothiadiazole inhibitor of c-met protein kinase

a technology of c-met protein and inhibitor, which is applied in the field of selective inhibitors of c-met, can solve the problems of prolonging the qt interval, causing cardiac qt prolongation, adverse or fatal side effects in many clinical settings, etc., and achieves the effect of treating or lessening the severity of a proliferativ

Inactive Publication Date: 2011-12-08
LAUFFER DAVID +3
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This compound effectively inhibits c-Met activity with low hERG binding, providing a therapeutic benefit for treating proliferative disorders while minimizing cardiac risks and optimizing drug metabolism.

Problems solved by technology

Drug-induced cardiac QT prolongation has recently been recognized to cause adverse or fatal side-effects in many clinical settings.
It has been shown that inhibition of hERG potassium channel can lead to a prolongation of the QT interval, widely considered a critical risk factor for torsades de pointes (TdP) arrhythmia.
Thus, overcoming hERG binding has become a major hurdle in drug development.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triazolothiadiazole inhibitor of c-met protein kinase
  • Triazolothiadiazole inhibitor of c-met protein kinase
  • Triazolothiadiazole inhibitor of c-met protein kinase

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of 6-((S)-1-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl)ethyl)quinoline (compound 1)

[0080]As shown in step i of Scheme 1, concentrated sulfuric acid (206 mL, 3.868 mol) was added dropwise to a solution of 2-(quinolin-6-yl)acetic acid (compound 1001, 658.2 g, 3.516 mol, Okeanos Tech Co., Cat. No. OK-J-05024) in 6.5 liters of methanol. During the addition, a slight exotherm was observed. After the addition was complete, the reaction was stirred at reflux for 4 hours. After cooling, the volatiles were removed under reduced pressure, the resulting residue was diluted with 4 liters of ethyl acetate, cooled in an ice bath, treated with 2N NaOH (2.1 liters, 1.2 equiv.) until a pH of 4 was achieved, and then treated with saturated sodium bicarbonate until a pH of 8 was achieved. The layers were separated and the aqueous layer extracted twice with ethyl acetate. The combined organics were washed with saturated sodium bicarbonate, washed with water, ...

example 2

Crystallization of Compound 1 (Free Base)

[0087]To compound 1 (906 mg) was added 40 mL of acetonitrile and 10 mL of methanol. The solid was dissolved on a hot water bath at about 90° C. The solution was filtered off and was allowed to slowly evaporate at room temperature for 4 hours. Crystals gradually precipitated. The mother liquor was decanted and the solid was dried at room temperature under 4 mm Hg vacuum over night.

[0088]About 10 mg of compound 1, crystalline free base (FB), was loaded into a vial with a magnetic stir bar. About 150 μL of solvent were added to each vial. If compound 1 dissolved completely, more solid was added to the vial and stirring of the resulting slurry was continued at room temperature. The 4 day solution was filtered off using centrifuge filters and diluted in methanol to obtain solubility data by HPLC analysis. The results of the solubility study are shown in Table 1. X-ray diffraction data of the crystals in the slurry were collected after 4 and 14 day...

example 3

Salt Formation of Compound 1

[0090]The free base of compound 1 was dissolved in ethanol to make a solution of 0.02 mmol / mL concentration. Base and acid solutions were added to separate vials containing the solution and the solvents were then evaporated at room temperature under vacuum (4 mmHg pressure). 2-Propanol (IPA) and ethanol were individually added to separate vials to re-dissolve the solids and crystallization of the solid in each vial was attempted by slow evaporation at room temperature. The resulted solids were characterized by X-ray diffraction studies. The results are shown in Table 3.

TABLE 3Acid solutionIPA salt formEthanol salt formhydrochloric acidamorphousamorphoussulfuric acid 2:1 molar ratioCrystalline saltCrystalline saltp-toluenesulfonic acidamorphousamorphousFree baseCrystalline FBCrystalline FBmethanesulfonic acidamorphousamorphousbenzenesulfonic acidCrystalline saltamorphousmaleic acidamorphousamorphousL-prolineamorphousamorphousphosphoric acidCrystalline salt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders.

Description

TECHNICAL FIELD OF THE INVENTION[0001]The present invention relates to selective inhibitors of c-Met. The invention also provides pharmaceutically acceptable compositions comprising a c-Met inhibitor and methods of using the compositions in the treatment of various proliferative disorders.BACKGROUND OF THE INVENTION[0002]Hepatocyte growth factor (HGF), also known as scatter factor, is a multi-functional growth factor that enhances transformation and tumor development by inducing mitogenesis and cell motility. Further, HGF promotes metastasis by stimulating cell motility and invasion through various signaling pathways. In order to produce cellular effects, HGF must bind to its receptor, c-Met, a receptor tyrosine kinase. c-Met, a widely expressed heterodimeric protein comprising of a 50 kilodalton (kDa) α-subunit and a 145 kDa alpha-subunit (Maggiora et al., J. Cell Physiol., 173:183-186, 1997), is overexpressed in a significant percentage of human cancers and is amplified during the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K31/4709A61P35/00C07D215/12
CPCC07D513/04A61P11/00A61P35/00A61P35/04A61P43/00A61K31/433
InventorLAUFFER, DAVIDLI, PANSHANNON, DEANLIANG, JIANGLIN
OwnerLAUFFER DAVID